A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel

PHASE4RecruitingINTERVENTIONAL
Enrollment

295

Participants

Timeline

Start Date

March 9, 2022

Primary Completion Date

July 29, 2037

Study Completion Date

October 30, 2037

Conditions
Multiple Myeloma
Interventions
DRUG

Cilta-cel

Participants who had received cilta-cel in previous studies will be followed up in this study. No additional study treatment will be administered to participants in this study.

Trial Locations (48)

3000

RECRUITING

UZ Leuven, Leuven

9000

RECRUITING

UZ Gent, Ghent

10029

RECRUITING

Mount Sinai Medical Center, New York

10065

RECRUITING

Memorial Sloan Kettering Cancer Center, New York

10467

RECRUITING

Montefiore Medical Center, The Bronx

14263

RECRUITING

Roswell Park Cancer Institute, Buffalo

15232

RECRUITING

University of Pittsburgh Medical Center, Pittsburgh

19104

RECRUITING

University of Pennsylvania, Philadelphia

28204

RECRUITING

Levine Cancer Institute, Charlotte

30322

RECRUITING

Emory University, Atlanta

31008

RECRUITING

Clinica Univ. de Navarra, Pamplona

33612

RECRUITING

Moffitt Cancer Center, Tampa

37007

RECRUITING

Hosp Clinico Univ de Salamanca, Salamanca

37203

RECRUITING

Sarah Cannon Research Institute, Nashville

46202

RECRUITING

Indiana University, Indianapolis

48201

RECRUITING

Barbara Ann Karmanos Cancer Institute, Detroit

53226

RECRUITING

Froedtert Memorial, Milwaukee

55902

RECRUITING

Mayo Clinic Rochester, Rochester

59037

RECRUITING

CHRU de Lille Hopital Claude Huriez, Nord

60611

RECRUITING

Northwestern University, Chicago

60637

RECRUITING

University of Chicago, Chicago

63110

RECRUITING

Washington University School Of Medicine, St Louis

64239

RECRUITING

Tel Aviv Sourasky Medical Center, Tel Aviv

66205

RECRUITING

Kansas University Medical Center, Westwood

75010

RECRUITING

Hopital Saint Louis, Paris

77030

RECRUITING

MD Anderson Cancer Center, Houston

85054

RECRUITING

Mayo Clinic Cancer Center-Scottsdale, Phoenix

91010

RECRUITING

City of Hope, Duarte

94143

RECRUITING

University of California San Francisco, San Francisco

100191

RECRUITING

Peking University Third Hospital, Beijing

200003

RECRUITING

Shanghai Changzheng Hospital, Shanghai

200025

RECRUITING

Ruijin Hospital Shanghai Jiao Tong University, Shanghai

200434

RECRUITING

Shanghai Fourth People s Hospital, Shanghai

210029

RECRUITING

Jiangsu Province Hospital, Nanjing

310003

RECRUITING

First Hospital, Zhejiang University Medical College, Hangzhou

350000

RECRUITING

Fujian Medical University Union Hospital, Fuzhou

610041

RECRUITING

West China Hospital Si Chuan University, Chengdu

710004

RECRUITING

The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an

94305-5623

RECRUITING

Stanford University Medical Center, Stanford

02115

RECRUITING

Dana Farber Cancer Institute, Boston

02215

RECRUITING

Beth Israel Deaconess Medical Center, Boston

RECRUITING

Massachusetts General Hospital, Boston

07601

RECRUITING

Hackensack University Medical Center, Hackensack

08903

RECRUITING

Rutgers Cancer Institute of New Jersey, New Brunswick

467 8602

ACTIVE_NOT_RECRUITING

Nagoya City University Hospital, Nagoya

150-8935

ACTIVE_NOT_RECRUITING

Japanese Red Cross Medical Center, Shibuya City

1081 HV

RECRUITING

VU Medisch Centrum, Amsterdam

9713 GZ

RECRUITING

University Medical Center Groningen, Groningen

All Listed Sponsors
lead

Janssen Research & Development, LLC

INDUSTRY